Type 2 diabetes mellitus (T2DM) is one of the common metabolic diseases in the world. Due
to the rise in morbidity and mortality, it has become a global health problem. To date, T2DM …

Gut microbiota and its metabolites such as short chain fatty acids (SCFA),
lipopolysaccharides (LPS), and trimethylamine-N-oxide (TMAO) impact cardiovascular …

To study the effect of host genetics on gut microbiome composition, the MiBioGen
consortium curated and analyzed genome-wide genotypes and 16S fecal microbiome data …

The increasing prevalence of diabetes and its complications, such as cardiovascular and
kidney disease, remains a huge burden globally. Identification of biomarkers for the …

Atherosclerosis, chronic non-communicable diseases, and metabolic syndrome are highly
interconnected and collectively contribute to global health concerns that reduce life …

Background Previous researches have implicated a vital association between gut microbiota
(GM) and diabetic retinopathy (DR) based on the association of the “gut-retina” axis. But …

In many non-Asian countries, soy is consumed via soy-based meat and dairy alternatives, in
addition to the traditional Asian soyfoods, such as tofu and miso. Meat alternatives are …

Background An association between Graves' disease (GD) and the gut microbiome has
been identified, but the causal effect between them remains unclear. Methods Bidirectional …

Trimethylamine-N-oxide (TMAO) is the main diet-induced metabolite produced by the gut
microbiota, and it is mainly eliminated through renal excretion. TMAO has been correlated …

Mounting evidence suggested that the gut microbiota has a significant role in the
metabolism and disease status of the host. In particular, Type 2 Diabetes (T2D), which has a …